4.5 Article

PYDDT, a novel phase 2 enzymes inducer, activates Keap1-Nrf2 pathway via depleting the cellular level of glutathione

Journal

TOXICOLOGY LETTERS
Volume 199, Issue 1, Pages 93-101

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.toxlet.2010.08.011

Keywords

Glutathione; Keap1-Nrf2 pathway; PYDDT; S-glutathionylation

Categories

Funding

  1. Zhejiang Key Science & Technological Program [2009C13028]
  2. Zhejiang Innovation Program for Graduates [YK2009015]

Ask authors/readers for more resources

Keap1-Nrf2 pathway has emerged as a regulator for the endogenous antioxidant response, which is critical in defending cells against carcinogenesis. Herein, we demonstrated that depleting the cellular level of glutathione (GSH) by a novel electrophilic agent 2-(pro-1-ynyl)-5-(5,6-dihydroxypenta-1,3-diynyl) thiophene (PYDDT) could activate Keap1-Nrf2 pathway. In above process, it was found that Keap1 was modified by S-glutathionylation, an important post-translational modification of protein cysteines with critical roles in oxidative stress and signal transduction. We concluded from our findings that conjugation with intracellular GSH by PYDDT might lead to Keap1 S-glutathionylation and was a key event involved in its Nrf2 inducing activity. (C) 2010 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available